Chronic granulomatous disease: 14 cases;Granulomatose septique chronique: 14 observations

Presse Medicale

Volumn 28, Issue 37, 1999, Pages 2034-2036

  Barbouche, M R ^a   Sghiri, R ^a   Mellouli, F ^a   Boukhdir, Y ^a   Dellagi, K ^a   Bejaoui M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHEMOLUMINESCENCE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONSANGUINITY; FEMALE; HUMAN; LUNG ASPERGILLOSIS; MALE; NITROBLUE TETRAZOLIUM TEST; ONSET AGE; PROGNOSIS; RECURRENT INFECTION; RESPIRATORY BURST;

ASPERGILLOSIS; BACTERIAL INFECTIONS; CHEMILUMINESCENT MEASUREMENTS; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNE TOLERANCE; INFANT; MALE; NEUTROPHILS; OPPORTUNISTIC INFECTIONS; RESPIRATORY BURST; RETROSPECTIVE STUDIES;

EID: 0033610687     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Primary immunodeficiency diseases. Report of World Health Organization (WHO) scientific group. Clin Exp Immunol 1997 ; 109(suppl. 1):1-28.
2. Meischl C, Roos D, The molecular basis of chronic granulomatous disease. Springer Semin Immunopathol 1998 ; 19:417-34.
3. Bejaoui M, Barbouche MR, Sassi A et al. Les déficits immunitaires primitifs en Tunisie : étude de 152 cas. Arch Pediatr 1997; 4:827-31.
4. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity and prevention of infections in chronic granulomatous disease. J Pediatr 1989 ; 114:555-60.
5. Patino PJ, Perez JE, Lopez JA ef al. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox. Hum Mutat 1999 ; 13(1):29-37.
6. Mouy R, Ropert JC, Donadieu J et al. Granulomatose septique chronique révélée par une aspergillose pulmonaire néonatale. Arch Pediatr 1995 ; 2:861-64.
7. Liese JG, Jendrossek V, Janson A et al. Chronic granulomatous disease in adults. Lancet 1995;346:220-23.
8. Babior BM, Woodman RC. Chronic granulomatous disease. Semin Hemotol 1990 ; 27:247-59.
9. Lazarus GE, Neu HC. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr 1975;86:415-17.
10. Kobayashi Y, Amano D, Veda K, Kagosaki Y, Usui J. Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole trimethoprim. Eur J Pediatr 1978 ; 127:247-51.
11. Cohen MS, Isturiz RE, Malech ML et al. Fungal infection in chronic granulomatous disease : the importance of the phagocyte in defense against fungi. Am J Med 1981 ; 71:59-66.
12. Mouy R, Bremard C, Fischer A, Huu Trong P, Vilmer E, Griscelli C. Infection aspergillaire et granulomatose septique chronique. Arch Fr Pediatr 1985 ; 42:953-57.
13. Tauber AL, Borregaard N, Simmons E, Wricht J. Chronic granulomatous disease : a syndrome of phagocyte oxidase deficiencies. Medicine 1983 ; 62:286-309.
14. Weening RS, Adriaansz LH, Weemaes CMR, Lutter R, Roos D. Clinical differences in chronic granulomatous disease in patients with cytodirome b-negative or cytochrome b- positive neutrophils. J Pediatr 1985 ; 107:102-65.
15. Roos D, de Boer M, Kuribayashi F et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996 ; 87:1663-81.
16. Margolis DM, Melnick DA, Alling DW, Gallin JL. Trimethoprim-surfamethoxazole prophylaxis in the management of chronic granullomatous disease. J Infect Dis 1990 ; 162:723-26.
17. Mouy R, Veber F, Blanche S et al. Long term intraconazole prophylaxis against aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 1994 ; 125:998-1003.
18. International chronic granulomatous disease cooperative study group : a controlled trial of Interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991 ;324:509-16.
19. Weening RS, Letz GJ, Seger RA. Recombinant human interferon-gamma in patients with chronic granulomatous disease. European follow-up stydy. Eur J Pediatr 1995 ; 154:295.